193 related articles for article (PubMed ID: 24691683)
1. Alternatives to carbapenems for infections caused by ESBL-producing Enterobacteriaceae.
Pilmis B; Parize P; Zahar JR; Lortholary O
Eur J Clin Microbiol Infect Dis; 2014 Aug; 33(8):1263-5. PubMed ID: 24691683
[No Abstract] [Full Text] [Related]
2. Extended-spectrum β-lactamase-producing Enterobacteriaceae, national study of antimicrobial treatment for pediatric urinary tract infection.
Lagree M; Bontemps S; Dessein R; Angoulvant F; Madhi F; Martinot A; Cohen R; Dubos F;
Med Mal Infect; 2018 May; 48(3):193-201. PubMed ID: 29449049
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of empirical therapy with non-carbapenems for urinary tract infections with extended-spectrum beta-lactamase-producing Enterobacteriaceae.
Asakura T; Ikeda M; Nakamura A; Kodera S
Int J Infect Dis; 2014 Dec; 29():91-5. PubMed ID: 25461239
[TBL] [Abstract][Full Text] [Related]
4. The challenges of carbapenemase-producing Enterobacteriaceae and infection prevention: protecting patients in the chaos.
Savard P; Carroll KC; Wilson LE; Perl TM
Infect Control Hosp Epidemiol; 2013 Jul; 34(7):730-9. PubMed ID: 23739078
[No Abstract] [Full Text] [Related]
5. Non-carbapenem therapy of urinary tract infections caused by extended-spectrum β-lactamase-producing Enterobacteriaceae.
de La Blanchardière A; Dargère S; Guérin F; Daurel C; Saint-Lorant G; Verdon R; Cattoir V
Med Mal Infect; 2015 May; 45(5):169-72. PubMed ID: 25845927
[TBL] [Abstract][Full Text] [Related]
6. The efficacy of cefmetazole against pyelonephritis caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae.
Doi A; Shimada T; Harada S; Iwata K; Kamiya T
Int J Infect Dis; 2013 Mar; 17(3):e159-63. PubMed ID: 23140947
[TBL] [Abstract][Full Text] [Related]
7. Outcome of urinary tract infections caused by extended spectrum β-lactamase-producing Enterobacteriaceae in children.
Tratselas A; Iosifidis E; Ioannidou M; Saoulidis S; Kollios K; Antachopoulos C; Sofianou D; Roilides EJ
Pediatr Infect Dis J; 2011 Aug; 30(8):707-10. PubMed ID: 21248655
[TBL] [Abstract][Full Text] [Related]
8. Cefepime versus carbapenems for the treatment of urinary tract infections caused by extended-spectrum β-lactamase-producing enterobacteriaceae.
Kim SA; Altshuler J; Paris D; Fedorenko M
Int J Antimicrob Agents; 2018 Jan; 51(1):155-158. PubMed ID: 28943367
[TBL] [Abstract][Full Text] [Related]
9. Carbapenems versus beta-lactam/beta-lactamase inhibitors to treat ESBL-producing Enterobacteriaceae infections.
Bru JP; Alfandari S; Bleibtreu A; Chavanet P; Gauzit R; Lescure X; Lesprit P; Tattevin P
Med Mal Infect; 2020 Jun; 50(4):313-315. PubMed ID: 31623961
[No Abstract] [Full Text] [Related]
10. Extended-spectrum beta-lactamases. An overview.
Patterson JE
Postgrad Med; 2001 Feb; 109(2 Suppl):32-8. PubMed ID: 19667555
[TBL] [Abstract][Full Text] [Related]
11. Ertapenem for the treatment of bloodstream infections due to ESBL-producing Enterobacteriaceae: a multinational pre-registered cohort study.
Gutiérrez-Gutiérrez B; Bonomo RA; Carmeli Y; Paterson DL; Almirante B; Martínez-Martínez L; Oliver A; Calbo E; Peña C; Akova M; Pitout J; Origüen J; Pintado V; García-Vázquez E; Gasch O; Hamprecht A; Prim N; Tumbarello M; Bou G; Viale P; Tacconelli E; Almela M; Pérez F; Giamarellou H; Cisneros JM; Schwaber MJ; Venditti M; Lowman W; Bermejo J; Hsueh PR; Mora-Rillo M; Gracia-Ahulfinger I; Pascual A; Rodríguez-Baño J;
J Antimicrob Chemother; 2016 Jun; 71(6):1672-80. PubMed ID: 26907184
[TBL] [Abstract][Full Text] [Related]
12. [Laboratory detection of carbapenemase-producing Enterobacteriaceae].
Cercenado E
Rev Esp Quimioter; 2015 Sep; 28 Suppl 1():8-11. PubMed ID: 26365726
[TBL] [Abstract][Full Text] [Related]
13. Should we consider faecal colonisation with extended-spectrum β-lactamase-producing Enterobacteriaceae in empirical therapy of community-onset sepsis?
Stupica D; Lusa L; Klevišar MN; Terzić S; Pirš M; Premru MM; Strle F
Int J Antimicrob Agents; 2017 Oct; 50(4):564-571. PubMed ID: 28711676
[TBL] [Abstract][Full Text] [Related]
14. Current options for the treatment of infections due to extended-spectrum beta-lactamase-producing Enterobacteriaceae in different groups of patients.
Gutiérrez-Gutiérrez B; Rodríguez-Baño J
Clin Microbiol Infect; 2019 Aug; 25(8):932-942. PubMed ID: 30986558
[TBL] [Abstract][Full Text] [Related]
15. Extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE) infections: are carbapenem alternatives achievable in daily practice?
Pilmis B; Delory T; Groh M; Weiss E; Emirian A; Lecuyer H; Lesprit P; Zahar JR
Int J Infect Dis; 2015 Oct; 39():62-7. PubMed ID: 26327124
[TBL] [Abstract][Full Text] [Related]
16. Distribution of ESBL-producing enterobacteria associated to community-acquired monomicrobial urinary tract infections and antimicrobial susceptibility trends over a 9-year period.
Dias VC; da Silva VL; Firmo Ede O; Bastos LQ; Bastos AN; Bastos RV; Diniz CG
J Chemother; 2012 Jun; 24(3):178-81. PubMed ID: 22759764
[No Abstract] [Full Text] [Related]
17. "Double carbapenem" and oral fosfomycin for the treatment of complicated urinary tract infections caused by bla
Rosa R; Rudin SD; Rojas LJ; Hujer AM; Perez-Cardona A; Perez F; Bonomo RA; Martinez O; Abbo LM; Camargo JF
Transpl Infect Dis; 2018 Feb; 20(1):. PubMed ID: 29064133
[TBL] [Abstract][Full Text] [Related]
18. Temocillin use in England: clinical and microbiological efficacies in infections caused by extended-spectrum and/or derepressed AmpC β-lactamase-producing Enterobacteriaceae.
Balakrishnan I; Awad-El-Kariem FM; Aali A; Kumari P; Mulla R; Tan B; Brudney D; Ladenheim D; Ghazy A; Khan I; Virgincar N; Iyer S; Carryn S; Van de Velde S
J Antimicrob Chemother; 2011 Nov; 66(11):2628-31. PubMed ID: 21810837
[TBL] [Abstract][Full Text] [Related]
19. Global spread of New Delhi metallo-β-lactamase 1.
Bogaerts P; Verroken A; Jans B; Denis O; Glupczynski Y
Lancet Infect Dis; 2010 Dec; 10(12):831-2. PubMed ID: 21109171
[No Abstract] [Full Text] [Related]
20. Clinical effectiveness of carbapenems versus alternative antibiotics for treating ESBL-producing Enterobacteriaceae bacteraemia: a systematic review and meta-analysis.
Son SK; Lee NR; Ko JH; Choi JK; Moon SY; Joo EJ; Peck KR; Park DA
J Antimicrob Chemother; 2018 Oct; 73(10):2631-2642. PubMed ID: 29800480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
